natgillin/translations-raw huggingface dataset:
In order to avoid the premature obsolescence of articles that are no longer produced after the sunset dates referred to Annex XIV to Regulation (EC) No 1907/2006, some substances (by themselves or in mixtures) included in that Annex need to be available for the production of spare parts for the repair of those articles, where those articles cannot function as intended without those spare parts, as well as where some Annex XIV substances (by themselves or in mixtures) are necessary for the repair of such articles.
Kako bi se izbjeglo prerano zastarijevanje proizvoda koji se ne proizvode nakon datuma povlačenja iz Priloga XIV. Uredbi (EZ) br. 1907/2006, neke tvari (zasebno ili u smjesama) uvrštene u taj Prilog moraju biti na raspolaganju za proizvodnju rezervnih dijelova za popravak tih proizvoda ako ti proizvodi ne mogu obavljati svoju funkciju bez tih rezervnih dijelova, a i ako su neke tvari (zasebno ili u smjesama) iz Priloga XIV. potrebne za popravak tih proizvoda.
To that end, applications for authorisation for the use of an Annex XIV substance for the production of such spare parts and for the repair of such articles should be simplified.
U tu svrhu zahtjeve za autorizaciju uporabe tvari iz Priloga XIV. u proizvodnji tih rezervnih dijelova i za popravak tih proizvoda trebalo bi pojednostavniti.
The transitional arrangements applicable to the substances concerned by those uses should be extended in order to allow for the adoption of implementing measures for such simplified applications for authorisation.
Prijelazna rješenja koja se primjenjuju na tvari na koje se odnose te uporabe trebalo bi produljiti kako bi se uspjele donijeti provedbene mjere za te pojednostavnjene zahtjeve za autorizaciju.
N,N-Dimethylformamide (DMF) meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
N,N-dimetilformamid (DMF) ispunjuje kriterije prema kojima se tvari razvrstavaju kao reproduktivno toksične (kategorija 1.B) u skladu s Uredbom (EZ) br. 1272/2008 te stoga ispunjuje kriterije za uvrštenje u Prilog XIV. Uredbi (EZ) br. 1907/2006 utvrđene u članku 57. točki (c) te Uredbe.
It has also been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in Annex XIV to that Regulation by the Agency's recommendation of 6 February 2014 in accordance with Article 58 of that Regulation.
Osim toga, identificiran je i uvršten na popis tvari predloženih u skladu s člankom 59. Uredbe (EZ) br. 1907/2006 za prioritetno uvrštenje u Prilog XIV. toj Uredbi preporukom Agencije od 6. veljače 2014. u skladu s člankom 58. te Uredbe.
DMF has similar intrinsic properties to those of N,N-dimethylacetamide (DMAC) and N-methyl-2-pyrrolidone (NMP) and the three substances may be considered as potential alternatives for some of their major uses.
DMF ima slična unutarnja svojstva kao N,N-dimetilacetamid (DMAC) i N-metil-2-pirolidon (NMP) pa se te tri tvari mogu smatrati mogućim alternativama za neke od njihovih glavnih uporaba.
NMP is the subject of an on-going restriction procedure in accordance with Article 69 of Regulation (EC) No 1907/2006.
NMP je trenutačno predmet postupka uvođenja ograničenja u skladu s člankom 69. Uredbe (EZ) br. 1907/2006.
In view of the similarities of the three substances, both regarding their intrinsic properties and their industrial applications, and in order to ensure a consistent regulatory approach, the Commission considers it appropriate to postpone the decision on the inclusion of DMF in Annex XIV as has already been done for DMAC when the Commission considered the Agency's recommendation of 17 January 2013.
Zbog sličnosti tih triju tvari, i u smislu unutarnjih svojstava i u smislu industrijske primjene, te radi osiguranja dosljednog regulatornog pristupa Komisija smatra primjerenim odgoditi odluku o uvrštenju DMF-a u Prilog XIV. kao što je već učinjeno za DMAC kad je Komisija razmatrala preporuku Agencije od 17. siječnja 2013.
Diazene-1,2-dicarboxamide (C,C′-azodi(formamide)) (ADCA) meets the criteria for classification as a respiratory sensitiser (Resp. Sens.1).
Diazen-1,2-dikarboksamid (C,C′-azodi(formamid)) (ADCA) ispunjuje kriterije prema kojima se tvari razvrstavaju kao tvari koje izazivaju preosjetljivost dišnih putova (Resp. senz. 1).
Taking into account all available information about the intrinsic properties of ADCA and about its adverse effects, the Agency concluded that it can be regarded as a substance for which there is scientific evidence of probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in points (a) to (e) of Article 57 of Regulation (EC) No 1907/2006 and therefore meets the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(f) of that Regulation.
Uzimajući u obzir sve raspoložive informacije o unutarnjim svojstvima ADCA-a i o njegovim štetnim učincima, Agencija je zaključila da ga se može smatrati tvari za koju postoje znanstveni dokazi o vjerojatnim ozbiljnim učincima na zdravlje ljudi koji su jednako zabrinjavajući kao učinci drugih tvari iz točaka od (a) do (e) članka 57. Uredbe (EZ) br. 1907/2006 te stoga ispunjuje kriterije za uvrštenje u Prilog XIV. toj Uredbi utvrđene u članku 57. točki (f) te Uredbe.
Uses of ADCA are very diverse and concern a broad range of different manufacturing industries, expected to lead to highly complex applications for authorisation.
Uporabe ADCA-a prilično su raznolike i odnose se na širok spektar različitih proizvodnih industrija, zbog čega se očekuje da će se podnositi izrazito složeni zahtjevi za autorizaciju.
As currently the experience for handling authorisation applications covering broad ranges of uses is still limited, it is appropriate to postpone the decision on the inclusion of ADCA in Annex XIV, for the time being.
S obzirom na to da je iskustvo u obradi zahtjeva za autorizaciju kojima je obuhvaćen širok spektar uporaba i dalje ograničeno, zasad je primjereno odgoditi odluku o uvrštenju ADCA-a u Prilog XIV.
Certain aluminosilicate refractory ceramic fibres (Al-RCF) and zirconia aluminosilicate refractory ceramic fibres (Zr-RCF) meet the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a) of that Regulation.
Određena aluminosilikatna vatrootporna keramička vlakna (Al-RCF) i cirkonijeva aluminosilikatna vatrootporna keramička vlakna (Zr-RCF) ispunjuju kriterije prema kojima se tvari razvrstavaju kao kancerogene (kategorija 1.B) u skladu s Uredbom (EZ) br. 1272/2008 te stoga ispunjuju kriterije za uvrštenje u Prilog XIV. Uredbi (EZ) br. 1907/2006 utvrđene u članku 57. točki (a) te Uredbe.
They have also been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in Annex XIV to that Regulation by the Agency's recommendation of 6 February 2014 in accordance with Article 58 of that Regulation.
Osim toga, identificirana su i uvrštena na popis tvari predloženih u skladu s člankom 59. Uredbe (EZ) br. 1907/2006 za prioritetno uvrštenje u Prilog XIV. toj Uredbi preporukom Agencije od 6. veljače 2014. u skladu s člankom 58. te Uredbe.
The actual fibres are manufactured at a very limited number of industrial sites and are in general directly transformed within the same manufacturing process into articles that are subsequently used in a broad range of industrial equipment for high-temperature insulation, which can potentially lead to significant worker exposure.
Konkretna vlakna proizvode se u vrlo ograničenom broju industrijskih postrojenja i općenito se izravno preoblikuju u okviru istog proizvodnog procesa u proizvode koji se potom upotrebljavaju u širokom spektru industrijske opreme za toplinsku izolaciju, što može dovesti do znatnog izlaganja radnika.
However, the use of articles made of the fibres is not subject to authorisation under Regulation (EC) No 1907/2006.
Međutim, uporaba proizvoda od vlakana ne podliježe autorizaciji u skladu s Uredbom (EZ) br. 1907/2006.
In order to decide on the most relevant regulatory approach, the Commission considers it appropriate to postpone the decision on the inclusion of Al-RCF and Zr-RCF in Annex XIV to Regulation (EC) No 1907/2006 for the time being.
Kako bi odlučila koji je regulatorni pristup najrelevantniji, Komisija smatra primjerenim zasad odgoditi odluku o uvrštenju vlakana Al-RCF i Zr-RCF u Prilog XIV. Uredbi (EZ) br. 1907/2006.
Boric acid, disodium tetraborate (anhydrous), diboron trioxide, and tetraboron disodium heptaoxide (hydrate) meet the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Borna kiselina, dinatrijev tetraborat (bezvodni), diborov trioksid i tetraborov dinatrijev heptaoksid (hidrat) ispunjuju kriterije prema kojima se tvari razvrstavaju kao reproduktivno toksične (kategorija 1.B) u skladu s Uredbom (EZ) br. 1272/2008 te stoga ispunjuju kriterije za uvrštenje u Prilog XIV. Uredbi (EZ) br. 1907/2006 utvrđene u članku 57. točki (c) te Uredbe.
They have also been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in Annex XIV to that Regulation by the Agency's recommendation of 1 July 2015 in accordance with Article 58 of that Regulation.
Osim toga, identificirani su i uvršteni na popis tvari predloženih u skladu s člankom 59. Uredbe (EZ) br. 1907/2006 za prioritetno uvrštenje u Prilog XIV. toj Uredbi preporukom Agencije od 1. srpnja 2015. u skladu s člankom 58. te Uredbe.
Furthermore, the uses of these substances are very diverse and concern a broad range of different manufacturing industries, expected to lead to highly complex applications for authorisation.
Nadalje, uporabe tih tvari prilično su raznolike i odnose se na širok spektar različitih proizvodnih industrija, zbog čega se očekuje da će se podnositi izrazito složeni zahtjevi za autorizaciju.
As currently the experience for handling authorisation applications covering broad ranges of uses is still limited, it is appropriate to postpone the decision on the inclusion of these substances in Annex XIV for the time being.
S obzirom na to da je iskustvo u obradi zahtjeva za autorizaciju kojima je obuhvaćen širok spektar uporaba i dalje ograničeno, zasad je primjereno odgoditi odluku o uvrštenju tih tvari u Prilog XIV.
Annex XIV to Regulation (EC) No 1907/2006 is amended in accordance with the Annex to this Regulation.
Prilog XIV. Uredbi (EZ) br. 1907/2006 mijenja se u skladu s Prilogom ovoj Uredbi.
Regulation (EC) No 1272/2008 of the European Parliament and the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures (OJ L 353, 31.12.2008, p. 1).
Uredba (EZ) br. 1272/2008 Europskog parlamenta i Vijeća od 16. prosinca 2008. o razvrstavanju, označivanju i pakiranju tvari i smjesa (SL L 353, 31.12.2008., str. 1.).
The table in Annex XIV to Regulation (EC) No 1907/2006 is amended as follows:
Tablica u Prilogu XIV. Uredbi (EZ) br. 1907/2006 mijenja se kako slijedi:
Transitional arrangements
Prijelazna rješenja
Entry Nr
Unos br.
Intrinsic property(ies) referred to in Article 57
Bitno svojstvo/svojstva na koje upućuje članak 57.
Latest application date [1]
Najkasniji datum primjene [1]
Sunset date [2]
Datum povlačenja [2]
Exempted (categories of) uses
Izuzete (kategorije) upotrebe
Review periods
Razdoblje revizije
romopropane (n-propyl bromide)
rompropan (n-propil-bromid)
EC No 203-445-0
EZ br. 203-445-0
CAS No 106-94-5
CAS br. 106-94-5
Toxic for reproduction
Reproduktivno toksičan
(category 1B)
(kategorija 1.B)
4 January 2019
4. siječnja 2019.
4 July 2020
4. srpnja 2020.
Diisopentylphthalate
Diizopentilftalat
EC No 210-088-4
EZ br. 210-088-4
CAS No 605-50-5
CAS br. 605-50-5
1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7 rich
1,2-benzendikarboksilna kiselina, di-C6-8-razgranati alkilesteri, s velikim udjelom C7
EC No 276-158-1
EZ br. 276-158-1
CAS No 71888-89-6
CAS br. 71888-89-6
1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters
1,2-benzendikarboksilna kiselina, di-C7-11-razgranati i linearni alkilesteri
EC No 271-084-6
EZ br. 271-084-6
CAS No 68515-42-4
CAS br. 68515-42-4
1,2-Benzenedicarboxylic acid, dipentylester, branched and linear
1,2-benzendikarboksilna kiselina, dipentilester, razgranati i linearni
EC No 284-032-2
EZ br. 284-032-2
CAS No 84777-06-0
CAS br. 84777-06-0
Bis(2-methoxyethyl) phthalate
Bis(2-metoksietil)ftalat
EC No 204-212-6
EZ br. 204-212-6
CAS No 117-82-8
CAS br. 117-82-8
Dipentylphthalate
Dipentilftalat
EC No 205-017-9
EZ br. 205-017-9
CAS No 131-18-0
CAS br. 131-18-0
N-pentyl-isopentylphthalate
N-pentil-izopentilftalat
CAS No 776297-69-9
CAS br. 776297-69-9
Anthracene oil
Antracensko ulje
EC No 292-602-7
EZ br. 292-602-7
CAS No 90640-80-5
CAS br. 90640-80-5
Carcinogenic
Kancerogen
(category 1B)***, PBT, vPvB
(kategorija 1.B)***, PBT, vPvB
4 April 2019
4. travnja 2019.
4 October 2020
4. listopada 2020.
Pitch, coal tar, high temp.
Smola, ugljeni katran, visokotemperaturni
EC No 266-028-2
EZ br. 266-028-2
CAS No 65996-93-2
CAS br. 65996-93-2
(category 1B), PBT, vPvB
(kategorija 1.B), PBT, vPvB
4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated
4-(1,1,3,3-tetrametilbutil)fenol, etoksiliran
(covering well-defined substances and UVCB substances, polymers and homologues)
[obuhvaćajući točno definirane tvari i UVCB tvari, polimere i homologne tvari]
CAS No —
CAS br. —
Endocrine disrupting properties (Article 57(f) — environment)
Svojstva endokrine disrupcije (članak 57. točka (f) – okoliš)
4 July 2019
4. srpnja 2019.
4 January 2021
4. siječnja 2021.
onylphenol, branched and linear, ethoxylated
onilfenol, razgranati i linearni, etoksiliran
(substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof)
[tvari s linearnim i/ili razgranatim alkilnim lancem s brojem atoma ugljika 9 u kovalentnoj vezi na poziciji 4 s fenolom, etoksiliranim, obuhvaćajući UVCB tvari i točno definirane tvari, polimere i homologne tvari, koje uključuju bilo koji pojedinačni izomer i/ili njegove kombinacije]
The sign ‘(*)’ is inserted next to the date indicated in the ‘Latest application date’ column for the following substance entry numbers: 4, 5, 6, 7, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 25, 27, 28, 29, 30 and 31.
Znak „(*)” umeće se uz datum naveden u stupcu „Najkasniji datum primjene” za sljedeće brojeve unosa tvari: 4., 5., 6., 7., 10., 11., 12., 14., 15., 16., 17., 18., 19., 20., 21., 22., 23., 25., 27., 28., 29., 30. i 31.
The sign ‘(**)’ is inserted next to the date indicated in the ‘Sunset date’ column for the following substance entry numbers: 4, 5, 6, 7, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 25, 27, 28, 29, 30 and 31.
Znak „(**)” umeće se uz datum naveden u stupcu „Datum povlačenja” za sljedeće brojeve unosa tvari: 4., 5., 6., 7., 10., 11., 12., 14., 15., 16., 17., 18., 19., 20., 21., 22., 23., 25., 27., 28., 29., 30. i 31.
The following notes are inserted after the table:
Sljedeće se napomene umeću nakon tablice:
1 September 2019 for the use of the substance in the production of spare parts for the repair of articles the production of which ceased or will cease before the sunset date indicated in the entry for that substance, where that substance was used in the production of those articles and the latter cannot function as intended without that spare part, and for the use of the substance (on its own or in a mixture) for the repair of such articles where that substance on its own or in a mixture was used in the production of those articles and the latter cannot be repaired otherwise than by using that substance.
1. rujna 2019. za uporabu tvari u proizvodnji rezervnih dijelova za popravak proizvoda koji su se prestali proizvoditi ili će se prestati proizvoditi prije datuma povlačenja navedenog pod unosom za tu tvar, ako se ta tvar upotrebljavala u proizvodnji tih proizvoda, a oni ne mogu obavljati svoju funkciju bez tog rezervnog dijela, te za uporabu te tvari (zasebno ili u smjesi) za popravak tih proizvoda ako se ta tvar upotrebljavala zasebno ili u smjesi u proizvodnji tih proizvoda, a oni se ne mogu popraviti a da se ne upotrijebi ta tvar.
1 March 2021 for the use of the substance in the production of spare parts for the repair of articles the production of which ceased or will cease before the sunset date indicated in the entry for that substance, where that substance was used in the production of those articles and the latter cannot function as intended without those spare parts, and for the use of the substance (on its own or in a mixture) for the repair of such articles, where that substance was used in the production of those articles and the latter cannot be repaired otherwise than by using that substance.
1. ožujka 2021. za uporabu tvari u proizvodnji rezervnih dijelova za popravak proizvoda koji su se prestali proizvoditi ili će se prestati proizvoditi prije datuma povlačenja navedenog pod unosom za tu tvar, ako se ta tvar upotrebljavala u proizvodnji tih proizvoda, a oni ne mogu obavljati svoju funkciju bez tih rezervnih dijelova, te za uporabu te tvari (zasebno ili u smjesi) za popravak tih proizvoda ako se ta tvar upotrebljavala u proizvodnji tih proizvoda, a oni se ne mogu popraviti a da se ne upotrijebi ta tvar.
Does not meet the criteria for identification as a carcinogen if it contains < 0,005 % (w/w) benzo[a]pyrene (Einecs No 200-028-5)’
Ne ispunjava kriterije za određivanje kao kancerogena tvar ako sadržava < 0,005 % (masenog udjela) benzo[a]pirena (EINECS br. 200-028-5).”
Date referred to in Article 58(1)(c)(ii).
Datum iz članka 58. stavka 1. točke (c) podtočke ii.
Date referred to in Article 58(1)(c)(i).
Datum iz članka 58. stavka 1. točke (c) podtočke i.
EC No —
EZ br. —
Commission Regulation (EU) 2017/1000
Uredba Komisije (EU) 2017/1000
amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards perfluorooctanoic acid (PFOA), its salts and PFOA-related substances
o izmjeni Priloga XVII. Uredbi (EZ) br. 1907/2006 Europskog parlamenta i Vijeća o registraciji, evaluaciji, autorizaciji i ograničavanju kemikalija (REACH) u pogledu perfluorooktanske kiseline (PFOA), njezinih soli i tvari srodnih PFOA-i
Perfluorooctanoic acid (‘PFOA’), its salts and PFOA-related substances [2] have some specific properties such as high friction resistance, dielectricality, resistance to heat and chemical agents, and low surface energy.
Perfluorooktanska kiselina (PFOA), njezine soli i tvari srodne PFOA-i [2] imaju posebna svojstva poput visoke otpornosti na trenje, dielektričnosti, otpornosti na toplinu i kemijska sredstva te niske površinske energije.
They are used in a wide variety of applications such as in the fluoropolymer and fluoroelastomer production, as surfactants in fire-fighting foams, and in textile and paper production to provide water, grease, oil and/or dirt repellency.
Primjene su im brojne, a koriste se u proizvodnji fluoropolimera i fluoroelastomera, kao površinski aktivne tvari u pjenama za gašenje požara te u proizvodnji tekstila i papira za odbijanje vode, masnoća, ulja i/ili nečistoća.
On 14 June 2013, the Member State Committee, referred to in Article 76(1)(e) of Regulation (EC) No 1907/2006, identified PFOA as a persistent, bioaccumulative and toxic substance (‘PBT’) in accordance with Article 57(d) of that Regulation.
Dana 14. lipnja 2013. Odbor država članica iz članka 76. stavka 1. točke (e) Uredbe (EZ) br. 1907/2006 utvrdio je da je PFOA postojana, bioakumulativna i toksična tvar (PBT) u skladu s člankom 57. točkom (d) te Uredbe.
On 20 June 2013, PFOA was included in the Candidate List of Substances of Very High Concern (‘SVHC’) for possible inclusion in Annex XIV to Regulation (EC) No 1907/2006.
PFOA je 20. lipnja 2013. predložena za moguće uvrštavanje u Prilog XIV. Uredbi (EZ) br. 1907/2006 kao posebno zabrinjavajuća tvar (SVHC).
On 17 October 2014, Germany and Norway submitted to the European Chemicals Agency (‘the Agency’) a dossier [3] pursuant to Article 69(4) of Regulation (EC) No 1907/2006 (‘the Annex XV dossier’), proposing to restrict the manufacture, placing on the market and use of PFOA, its salts and PFOA-related substances, in order to address the risks to human health and the environment.
Njemačka i Norveška su Europskoj agenciji za kemikalije (dalje u tekstu „Agencija”) 17. listopada 2014. dostavile dosje [3] u skladu s člankom 69. stavkom 4. Uredbe (EZ) br. 1907/2006 (dalje u tekstu „dosje iz Priloga XV.”) te su predložile ograničavanje proizvodnje, stavljanja na tržište i upotrebe PFOA-e, njezinih soli i tvari srodnih PFOA-i kako bi se ublažili rizici za ljudsko zdravlje i okoliš.
Germany and Norway proposed a concentration limit of 2 ppb for the presence of these substances in other substances, mixtures or articles, and did not propose exemptions except for second-hand articles for which an end-use in the Union can be demonstrated before the date of application of the restriction.
Njemačka i Norveška predložile su graničnu vrijednost koncentracije od 2 ppb za prisutnost tih tvari u drugim tvarima, smjesama ili proizvodima te nisu predložile izuzeća, osim kad je riječ o rabljenim proizvodima čiju je krajnju uporabu u Uniji moguće dokazati prije datuma primjene tog ograničenja.
On 8 September 2015, the Agency's Committee for Risk Assessment (‘RAC’) adopted its opinion concluding that subject to modification of the scope and conditions proposed in the Annex XV dossier, a general restriction on manufacture, use and placing on the market of PFOA, its salts and PFOA-related substances, is the most appropriate Union-wide measure to address the identified risks in terms of effectiveness in reducing those risks.
Dana 8. rujna 2015. Agencijin Odbor za procjenu rizika (RAC) donio je mišljenje u kojem je zaključio da je, podložno promjeni područja primjene i uvjeta predloženih u dosjeu iz Priloga XV., opće ograničenje proizvodnje, upotrebe i stavljanja na tržište PFOA-e, njezinih soli i tvari srodnih PFOA-i najprimjerenija mjera na razini Unije za ublažavanje utvrđenih rizika u smislu učinkovitog smanjenja tih rizika.
RAC proposed two different concentration limits, namely 25 ppb for PFOA and its salts and 1000 ppb for one or a combination of PFOA-related substances, in other substances, mixtures or articles, reflecting the possible presence of unavoidable impurities and unintended contaminants, and taking account of the capabilities of analytical methods.
RAC je predložio dvije različite granične vrijednosti koncentracije, odnosno 25 ppb za PFOA-u i njezine soli te 1000 ppb za jednu od tvari srodnih PFOA-i ili njihovu kombinaciju u drugim tvarima, smjesama ili proizvodima čime se odražava moguća prisutnost neizbježnih nečistoća i nenamjernih kontaminanata i uzimajući u obzir mogućnosti analitičkih metoda.
RAC proposed to exempt from the restriction photographic coatings applied to films, papers or printing plates, implantable medical devices and substances or mixtures used in semiconductor and photolithography processes, considering the relatively low environmental impact and long substitution timeframes.
RAC je predložio da se iz ograničenja izuzmu fotografski premazi naneseni na filmove, papir ili tiskarske ploče, medicinski proizvodi za ugradnju te tvari i smjese upotrijebljene u poluvodičkim i fotolitografskim postupcima jer je njihov utjecaj na okoliš relativno malen, dok su vremenski okviri za njihovu zamjenu dugi.